These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 23417677)

  • 21. FOXP3+Helios+ Regulatory T Cells, Immune Activation, and Advancing Disease in HIV-Infected Children.
    Khaitan A; Kravietz A; Mwamzuka M; Marshed F; Ilmet T; Said S; Ahmed A; Borkowsky W; Unutmaz D
    J Acquir Immune Defic Syndr; 2016 Aug; 72(5):474-84. PubMed ID: 27003495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HSP70 enhances immunosuppressive function of CD4(+)CD25(+)FoxP3(+) T regulatory cells and cytotoxicity in CD4(+)CD25(-) T cells.
    Wachstein J; Tischer S; Figueiredo C; Limbourg A; Falk C; Immenschuh S; Blasczyk R; Eiz-Vesper B
    PLoS One; 2012; 7(12):e51747. PubMed ID: 23300563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Forced overexpression of either of the two common human Foxp3 isoforms can induce regulatory T cells from CD4(+)CD25(-) cells.
    Aarts-Riemens T; Emmelot ME; Verdonck LF; Mutis T
    Eur J Immunol; 2008 May; 38(5):1381-90. PubMed ID: 18412171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory T cells in the pathogenesis and healing of chronic human dermal leishmaniasis caused by Leishmania (Viannia) species.
    Rodriguez-Pinto D; Navas A; Blanco VM; Ramírez L; Garcerant D; Cruz A; Craft N; Saravia NG
    PLoS Negl Trop Dis; 2012; 6(4):e1627. PubMed ID: 22545172
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CCL11 increases the proportion of CD4+CD25+Foxp3+ Treg cells and the production of IL‑2 and TGF‑β by CD4+ T cells via the STAT5 signaling pathway.
    Wang R; Huang K
    Mol Med Rep; 2020 Jun; 21(6):2522-2532. PubMed ID: 32323817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD4+CD25highFoxP3+ regulatory T-cells in hematologic diseases.
    Moon HW; Kim BH; Park CM; Hur M; Yun YM; Kim SY; Lee MH
    Korean J Lab Med; 2011 Oct; 31(4):231-7. PubMed ID: 22016675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defects in IL-2R signaling contribute to diminished maintenance of FOXP3 expression in CD4(+)CD25(+) regulatory T-cells of type 1 diabetic subjects.
    Long SA; Cerosaletti K; Bollyky PL; Tatum M; Shilling H; Zhang S; Zhang ZY; Pihoker C; Sanda S; Greenbaum C; Buckner JH
    Diabetes; 2010 Feb; 59(2):407-15. PubMed ID: 19875613
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptosis signaling is altered in CD4⁺CD25⁺FoxP3⁺ T regulatory lymphocytes in pre-eclampsia.
    Darmochwal-Kolarz D; Saito S; Tabarkiewicz J; Kolarz B; Rolinski J; Leszczynska-Gorzelak B; Oleszczuk J
    Int J Mol Sci; 2012; 13(6):6548-6560. PubMed ID: 22837649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are CD4+CD25-Foxp3+ cells in untreated new-onset lupus patients regulatory T cells?
    Yang HX; Zhang W; Zhao LD; Li Y; Zhang FC; Tang FL; He W; Zhang X
    Arthritis Res Ther; 2009; 11(5):R153. PubMed ID: 19821980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of a CD4+CD25+ Foxp3+T cells subset in Egyptian Colorectal Cancer Patients.
    Elsheshtawy NM; Saad M; El-Ghamrini YM; Ziada KW
    Egypt J Immunol; 2021 Jul; 28(3):145-156. PubMed ID: 34453786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes.
    Brusko T; Wasserfall C; McGrail K; Schatz R; Viener HL; Schatz D; Haller M; Rockell J; Gottlieb P; Clare-Salzler M; Atkinson M
    Diabetes; 2007 Mar; 56(3):604-12. PubMed ID: 17327427
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regulatory T cells express Tumor Necrosis Factor Receptor 2 with the highest intensity among CD4
    Ghods A; Mehdipour F; Shariat M; Talei AR; Ghaderi A
    Mol Immunol; 2021 Sep; 137():52-56. PubMed ID: 34214829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. PIM1 kinase phosphorylates the human transcription factor FOXP3 at serine 422 to negatively regulate its activity under inflammation.
    Li Z; Lin F; Zhuo C; Deng G; Chen Z; Yin S; Gao Z; Piccioni M; Tsun A; Cai S; Zheng SG; Zhang Y; Li B
    J Biol Chem; 2014 Sep; 289(39):26872-26881. PubMed ID: 25096571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypomethylation at the regulatory T cell-specific demethylated region in CD25hi T cells is decoupled from FOXP3 expression at the inflamed site in childhood arthritis.
    Bending D; Pesenacker AM; Ursu S; Wu Q; Lom H; Thirugnanabalan B; Wedderburn LR
    J Immunol; 2014 Sep; 193(6):2699-708. PubMed ID: 25092890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
    Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
    Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subpopulations of T Regulatory Cells in Blood Stem Cell Harvests Influence Development of Acute Graft Versus Host Disease in Allogeneic Transplant Recipients.
    Roschupkina T; Juliusson G
    Cytometry B Clin Cytom; 2018 Mar; 94(2):264-269. PubMed ID: 27479496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD4(+)CD25(+)CD127(low/-) regulatory T cells express Foxp3 and suppress effector T cell proliferation and contribute to gastric cancers progression.
    Shen LS; Wang J; Shen DF; Yuan XL; Dong P; Li MX; Xue J; Zhang FM; Ge HL; Xu D
    Clin Immunol; 2009 Apr; 131(1):109-18. PubMed ID: 19153062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Superantigen-induced proliferation of human CD4+CD25- T cells is followed by a switch to a functional regulatory phenotype.
    Taylor AL; Llewelyn MJ
    J Immunol; 2010 Dec; 185(11):6591-8. PubMed ID: 21048104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A unique subset of CD4+CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment.
    Strauss L; Bergmann C; Szczepanski M; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4345-54. PubMed ID: 17671115
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Significance of immunoregulatory T cells in different stages of breast cancer patients.
    Abo-Elenein A; Elgohary SE; Hashish A; El-Halaby E
    Egypt J Immunol; 2008; 15(2):145-52. PubMed ID: 20306697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.